國藥集團,集研發、生產、銷售、服務于一體的現代化綜合型制藥企業,擁有化學原料藥/無菌頭孢類抗生素原料藥/口服固體制劑/注射用粉針劑/中西藥口服液體制劑等產品
國(guo)藥(yao)(yao)集(ji)(ji)團(tuan)(tuan)(tuan)汕頭金石(shi)制(zhi)藥(yao)(yao)有(you)(you)限(xian)(xian)公(gong)(gong)(gong)司(si)(si)(原汕頭金石(shi)制(zhi)藥(yao)(yao)總廠)是中國(guo)醫藥(yao)(yao)集(ji)(ji)團(tuan)(tuan)(tuan)有(you)(you)限(xian)(xian)公(gong)(gong)(gong)司(si)(si)(國(guo)藥(yao)(yao)集(ji)(ji)團(tuan)(tuan)(tuan))所屬企(qi)業(ye)。2016年,根據國(guo)藥(yao)(yao)集(ji)(ji)團(tuan)(tuan)(tuan)化藥(yao)(yao)平臺整(zheng)合要求,國(guo)藥(yao)(yao)集(ji)(ji)團(tuan)(tuan)(tuan)所屬上(shang)(shang)市公(gong)(gong)(gong)司(si)(si)——上(shang)(shang)海現(xian)代制(zhi)藥(yao)(yao)股份有(you)(you)限(xian)(xian)公(gong)(gong)(gong)司(si)(si)完成對(dui)公(gong)(gong)(gong)司(si)(si)的重整(zheng),公(gong)(gong)(gong)司(si)(si)現(xian)為上(shang)(shang)海現(xian)代制(zhi)藥(yao)(yao)股份有(you)(you)限(xian)(xian)公(gong)(gong)(gong)司(si)(si)的全(quan)資子公(gong)(gong)(gong)司(si)(si)。
歷經多(duo)年發展,公(gong)司(si)現已發展成為(wei)具有(you)(you)化(hua)學原料藥(yao)、無菌頭孢(bao)類抗(kang)生素(su)原料藥(yao)、口服(fu)固體(ti)制(zhi)(zhi)劑(ji)、注射用粉(fen)針劑(ji)和中(zhong)西(xi)藥(yao)口服(fu)液體(ti)制(zhi)(zhi)劑(ji)等集(ji)研發、生產(chan)、銷售、服(fu)務于一(yi)體(ti)的現代(dai)化(hua)、綜(zong)合(he)型制(zhi)(zhi)藥(yao)企(qi)業,是汕(shan)頭金石(shi)粉(fen)針劑(ji)有(you)(you)限公(gong)司(si)、國藥(yao)集(ji)團汕(shan)頭金石(shi)抗(kang)菌素(su)有(you)(you)限公(gong)司(si)的控股股東。 公(gong)司(si)本部擁(yong)有(you)(you)制(zhi)(zhi)藥(yao)品種(zhong)(zhong)批文154個(ge),汕(shan)頭金石(shi)粉(fen)針劑(ji)有(you)(you)限公(gong)司(si)擁(yong)有(you)(you)不(bu)同(tong)品種(zhong)(zhong)批文65個(ge),國藥(yao)集(ji)團汕(shan)頭金石(shi)抗(kang)菌素(su)有(you)(you)限公(gong)司(si)擁(yong)有(you)(you)無菌頭孢(bao)類抗(kang)生素(su)原料藥(yao)4個(ge)品種(zhong)(zhong),尚有(you)(you)一(yi)批在研及申報品種(zhong)(zhong);本部及屬下所有(you)(you)生產(chan)線均通過(guo)2010年版GMP認證。全(quan)企(qi)業(含(han)屬下二個(ge)合(he)資公(gong)司(si))在職員工六百多(duo)人(ren)(ren),擁(yong)有(you)(you)一(yi)支素(su)養(yang)較高(gao)、實力(li)較雄(xiong)厚的生產(chan)、技術(shu)(shu)、經營和管(guan)理(li)隊伍(wu),其中(zhong)各類專業技術(shu)(shu)人(ren)(ren)員三百多(duo)人(ren)(ren)。
“精(jing)誠所(suo)至,金(jin)石(shi)為(wei)(wei)開”,國(guo)藥(yao)金(jin)石(shi),以優質(zhi)產品為(wei)(wei)載體(ti),以誠待(dai)客,誠信經營(ying),在國(guo)內外(wai)樹立(li)了良好的企業形象,產品出口歐洲、非(fei)洲、東南亞(ya),如德國(guo)、荷蘭、非(fei)洲、法國(guo)、日本等國(guo)家或地區(qu)。“雙(shuang)贏(ying)、多贏(ying)、合作(zuo)、誠信”,是建(jian)設(she)和(he)諧國(guo)藥(yao)金(jin)石(shi)的重要保障和(he)生動(dong)體(ti)現。國(guo)藥(yao)金(jin)石(shi)正(zheng)以科技創新為(wei)(wei)先導,以改革為(wei)(wei)動(dong)力,以海納(na)百川的胸(xiong)襟,聚眾才(cai),匯眾力,穩步(bu)邁向新境(jing)界。
放(fang)眼未來,公司將(jiang)一(yi)(yi)如既往秉(bing)承“關愛生(sheng)命 呵(he)護健康”的國(guo)藥理念,堅持“誠信(xin)經營(ying),質量第一(yi)(yi)”的經營(ying)宗旨(zhi),為建設國(guo)藥集團制藥產業基地(di)而努力,滿懷真誠和期望與各界朋友攜手共(gong)謀(mou)事業、共(gong)圖發展。